A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 15,202 shares of ARCT stock, worth $257,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,202
Previous 14,326 6.11%
Holding current value
$257,065
Previous $348,000 1.15%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $15,838 - $22,232
876 Added 6.11%
15,202 $352,000
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $348,838 - $635,931
14,326 New
14,326 $348,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $449M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.